Read more

December 13, 2020
1 min read
Save

Risk for GATT failure leads November glaucoma coverage

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Risk factors for GATT failure topped November glaucoma coverage on Healio/OSN. Read below for other popular glaucoma articles.

Younger children, those who do not receive anti-inflammatories at risk for GATT failure

Younger patients, patients who do not receive anti-inflammatory medications postoperatively and those who undergo non-circumferential angle surgery are at a higher risk for failure after gonioscopy-assisted transluminal trabeculotomy. Read more.

Late-stage neovascular glaucoma typically requires surgery, individualized management

Late-stage neovascular glaucoma can require surgical management, typically with a glaucoma drainage implant, but treatment should be individualized depending on patient factors. Read more.

Balance needed between glaucoma treatment, management of ocular surface disease

Glaucoma-related ocular surface disease is a significant and often underdiagnosed ocular comorbidity that can significantly affect quality of life. Read more.

VIDEO: Certain baseline characteristics predictive of Durysta duration of action

In this Healio Video Perspective from the virtual AAO annual meeting, Michael R. Robinson, MD, discusses patient characteristics affecting long-term IOP-lowering effects after implantation of Durysta (bimatoprost intracameral implant, AbbVie). Watch more.

VIDEO: Six-year results of iStent implantation

In this Healio Video Perspective from the virtual AAO annual meeting, Tanner Ferguson, MD, shares results from a study investigating 6-year outcomes of the iStent (Glaukos) with phacoemulsification. Watch more.